Chlamydia pneumoniae-based atherosclerosis: a smoking gun

References

• Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic smooth muscle cells. Infect Immun 1996; 64: 1614–20.
   Google Scholar
• Suvi-Sirkku E, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cul-tured human PBMC and induction of a cytokine response. Microbial Pathogenesis 1996; 21: 215–21.
   Google Scholar
• Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177: 725–9.
   Google Scholar
• Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine pro-duction and expression of CD14 in a human monocytic cell line. Infect Immun 1996; 64: 4872–5.
   Google Scholar
• Molestina RE, Miller RD, Ramirez JA, Summersgill JT. Infection of human endothelial cells with Chlamydia pneu-moniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 1999; 67: 1323–30.
   Google Scholar
• Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR; C. pneumoniae Workshop Participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492–503.
   Google Scholar
• Hoymans VY, Bosmans JM, Van Renterghem L, Mak R, Ursi D, Wuyts F, Vrints CJ, Ieven MM. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coro-nary atherosclerosis. J Clin Microbiol 2003; 41: 4049–53.
   Google Scholar
• Maraha B, den Heijer M, Kluytmans J, Peeters MF. Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases. Clin Diagn Lab Immunol 2004; 11: 789–91.
   Google Scholar
• Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Amesen H. Chlamydia pneumoniae serology: importance of methodology in patients with coro-nary heart disease and healthy individuals. J Clin Microbiol 2001; 39: 1859–64.
   Google Scholar
• Saikku P, LeInonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evi-dence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarc-tion. Lancet 1988; 2: 983–6.
   Google Scholar
• Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bemardes-Silva M, Ward M. Chlamy-dia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ2000; 321: 208-13.
   Google Scholar
• Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong Y-K, Thou X, Ward M. Chlamydia pneu-moniae IgA titres and coronary heart disease. Prospective study and meta-analysis. Eur Heart J2002; 23: 371-5.
   Google Scholar
• Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Multiple infec-tions and subsequent cardiovascular events in the Heart Out-comes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 251–7.
   Google Scholar
• Gaydos CA, Roblin PM, Hammerschlag MR, Hyman CL, Eiden JJ, Schachter J, Quinn TC. Diagnostic utility of PCR-enzyme immunoassay, culture and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32: 903–5.
   Google Scholar
• Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Voj-dani A, Rosenberg S, Samra Z. Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 2003; 22: 300–2.
   Google Scholar
• Gdoura R, Perreyre S, Frikha I, Hammami N, Clerc M, Sahnoun Y, Bebear C, Daoud M, de Barbeyrac B, Ham-mami A. Culture-negative endocarditis due to Chlamydia pneumoniae. J Clin Microbiol 2002; 40: 718–20.
   Google Scholar
• Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumo-niae (TWAR) in atherosclerosis of the carotid artery. Circu-lation 1995; 92: 3397–400.
   Google Scholar
• Juvonen J, Laurila A, Juvonen T, Alakdrppd A, Surcel H-M, Lounatmaa K, Kuusisto J, Saikku P. Detection of Chlamydia pneumoniae in human non-rheumatic stenotic aortic valves. J Am Coll Cardiol 1997; 29: 1054–9.
   Google Scholar
• Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Inf Dis 1993; 167: 841–9.
   Google Scholar
• Kuo CC, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT. Detection of Chlamy-dia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 1997; 26: 29–31.
   Google Scholar
• Ouchi K, Fujii B, Kanamoto Y, Karita M, Shirai M, Nakazawa T. Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovas-cular diseases. J Med Microbiol 1998; 47: 907–13.
   Google Scholar
• Valassina M, Migliorini L, Sansoni A, Sani G, Corsaro D, Cusi MG, Valensin PE, Cellesi C. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. J Med Microbiol 2001; 50: 228–32.
   Google Scholar
• Weiss SM, Roblin PM, Gaydos CA, Cummings PK, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J. Failure to detect Chlamy-dia pneumoniae in coronary atheromas of patients undergo-ing atherectomy. J Infect Dis 1996; 73: 957–62.
   Google Scholar
• Rose AG. Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aor-tic valve by immunofluorescence, polymerase chain reaction and electron microscopy. Cardiovasc Pathol 2002; 11: 300–4.
   Google Scholar
• Hoymans VY, Bosmans JM, Ursi D, Martinet W, Wuyts F, Van Marck E, Altwegg M, Vrints CJ, Ieven MM. Immuno-histostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents. J Clin Microbiol 2004; 42: 3219–24.
   Google Scholar
• Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol 1998; 51: 793–7.
   Google Scholar
• Vammen S, Vorum H, Ostergaard L, Henneberg EW, Lind-holt JS. Immunoblotting analysis of abdominal aortic aneurysms using antibodies against Chlamydia pneumoniae recombinant MOMP. Eur J Vasc Endovasc Surg 2002; 24: 81–5.
   Google Scholar
• Lindholt JS, Stovring J, Ostergaard L, Urbonavicius S, Hen-neberg EW, Honore B, Vorum H. Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 2004; 109: 2097–102.
   Google Scholar
• Neureiter D, Heuschmann P. Stintzing S, Kolominsky-Rabas P, Barbera L, Jung A, Ocker M, Maass M, Faller G, Kirch-ner T. Detection of Chlamydia pneumoniae but not of Heliobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis 2003; 168: 153–62.
   Google Scholar
• Ieven M, Hoymans VY. Involvement of Chlamydia pneu-moniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 2005; 43: 19–24.
   Google Scholar
• Apfalter P, Assadian 0, Blasi F, Gaydos CA, Kundi M, Makristathis A, Nehr M, Rotter ML, Hirschl AM. Relia-bility of nested PCR for detection of Chlamydia pneumo-niae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol 2002; 40: 4428–34.
   Google Scholar
• Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313–7.
   Google Scholar
• Ciervo A, Petrucca A, Cassone A. Identification and quan-tification of Chlamydia pneumoniae in human atheroscle-rotic plaques by LightCycler real-time-PCR. Mol Cell Probes 2003; 17: 107–11.
   Google Scholar
• Mygind T, Ostergaard L, Birkelund S, Lindholt JS, Chris-tiansen G. Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and esti-mation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair. BMC Microbiology 2003; 3: 19.
   Google Scholar
• Boman J, Söderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Edell E, Kumlin U, Juto P, Waldenstrom A, Wadell G. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with car-diovascular disease and in middle-aged blood donors. J Infect Dis 1998; 178: 274–7.
   Google Scholar
• Smieja M, Mahony J, Petrick A, Boman J, Chernesky M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systemic review. BMC Infect Dis 2002; 2:21.
   Google Scholar
• Taylor-Robinson D. Chlamydia pneumoniae in arteries: a tale of the unexpected. J Infect 1997; 35: 97–8.
   Google Scholar
• Gupta S, Leatham EW, Carrington D, Mendall MA, Kash JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–7.
   Google Scholar
• Sinisalo J, Mattila K, Valtonen V, Anttonen 0, Juvonen J, Melin J, Vuorinen-Markkola H, Nieminen MS; Clar-ithromycin in Acute Coronary Syndrome Patients in Fin-land (CLARIFY) Study Group. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome. Circulation 2002; 105: 1555–60.
   Google Scholar
• Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur Heart J 1999; 20: 121–7.
   Google Scholar
• Stone AFM, Mendall MA, Kash JC, Edger TM, Risley P, Poloniecki J, Camm AJ, Northfield TC. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on mark-ers of inflammation and cardiac events in patients with acute coronary syndromes. Circulation 2002; 106: 1219–23.
   Google Scholar
• Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M, Gottwik M, Altmann E, Seidel F, Rox J, Hoffler U, Neuhaus KL, Senges J; Working Group of Leading Hospi-tal Cardiologists. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation 2003; 107: 1253–9.
   Google Scholar
• Cercek B, Shah PK, Noc M, Zahger D, Zeymer U, Matetzky S, Maurer G, Mahrer P; AZACS Investigators. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003; 361: 809–13.
   Google Scholar
• Grayston JT. Antibiotic treatment of atherosclerotic car-diovascular disease. Circulation 2003; 107: 1228–30.
   Google Scholar
• Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muh-lestein B, Giugliano RP, Cairns R, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Throm-bolysis in Myocardial Infarction 22 Investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005; 352: 1646–54.
   Google Scholar
• Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muh-lestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C; ACES Investigators. Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005; 352: 1637–45.
   Google Scholar
• Muhlestein JB, Anderson JL, Carlquist SF, Salunkhe K, Home BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC Study. Circulation 2000; 102: 1755–60.
   Google Scholar